APLS · Apellis Pharmaceuticals, Inc.
Market Cap
$5.25B
Shares
128.02M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-04-28 | |
| 10-K/A | 2026-04-28 | 2025-12-31 | |
| 8-K | 2026-03-31 | 2026-03-30 | |
| 8-K | 2026-03-02 | 2026-02-27 | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-07-01 | — | |
| 8-K | 2025-06-04 | 2025-06-03 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-23 | — | |
| 8-K | 2025-04-21 | 2025-04-17 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-01-13 | 2025-01-08 | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-05 | — | |
| 8-K | 2024-05-14 | 2024-05-13 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | — | |
| 10-K/A | 2024-02-29 | 2023-12-31 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-22 | 2024-01-16 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-14 | — | |
| 8-K | 2023-12-01 | 2023-11-30 | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-11-01 | 2023-10-31 | |
| 8-K | 2023-10-05 | — | |
| 8-K | 2023-08-29 | 2023-08-28 | |
| 8-K | 2023-08-22 | — | |
| 10-Q | 2023-07-31 | 2023-06-30 | |
| 8-K | 2023-07-31 | — | |
| 8-K | 2023-07-17 | 2023-07-15 | |
| 8-K | 2023-06-01 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| DEF 14A | 2023-04-21 | 0001-01-01 | |
| 8-K | 2023-03-15 | — | |
| 8-K | 2023-02-24 | 2023-02-22 | |
| 10-K | 2023-02-21 | 2022-12-31 | |
| 8-K | 2023-01-09 | — | |
| 8-K | 2023-01-05 | 2023-01-03 | |
| 10-Q | 2022-11-07 | 2022-09-30 | |
| 8-K | 2022-08-24 | — | |
| 10-Q | 2022-08-08 | 2022-06-30 |
Showing 1–50 of 91 filings